Skip to content

Total debt at other companies

Insulet logo
InsuletPODD
$969.7M-45.5%
AdaptHealth logo
AdaptHealthAHCO
$2B-4.9%
Mannkind logo
MannkindMNKD
$12.24M-9.4%
Omnicell logo
OmnicellOMCL
$34.28M-23.1%
Medtronic logo
MedtronicMDT
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$247.2M+5.5%
Gross profit$136.8M+15.5%
Operating income-$17.4M+85.6%
Net income-$20.4M+84.4%
EPS (diluted)-$0.30+84.8%

Balance sheet

See full
Cash & equivalents$179.3M+235%
Total equity$132.4M-14.7%
Total assets$1.2B+25.1%

Cash flow

See full
Operating cash flow$11.1M+160%
CapEx$6.3M+111%
Free cash flow$4.8M+123%

Valuation

See full
Market cap$1.03B-23.6%
Enterprise value$1.58B-11.3%
P/S-0.4×

Profitability

See full
Gross margin54.9%+2.7pp
Operating margin-8.2%-2.9pp
Net margin-9.2%-3.1pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-65.7%-14.7pp
Debt / equity5.5×+2.4×
Current ratio3.6×+1.3×

Where this comes from

Calculated from Tandem Diabetes Care’s reported figures.

Plus components not separately reported this period.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tandem Diabetes Care's total debt?
Tandem Diabetes Care (TNDM) reported total debt of $734.74M in Q1 2026.
How has Tandem Diabetes Care's total debt changed year-over-year?
Tandem Diabetes Care's total debt increased by 49.0% year-over-year, from $493.2M to $734.74M.
What is the long-term trend for Tandem Diabetes Care's total debt?
Over 5 years (2020 to 2025), Tandem Diabetes Care's total debt has grown at a 77.3% compound annual growth rate (CAGR), from $25.34M to $444.48M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.